Connect with us

MLB Trade Rumors and News: Kelenic and Gilbert get the call to the show, Soroka suffers setback

Rick Scuteri-USA TODAY SportsThe Mariners are bringing up two of their best prospects while the Braves will be without one of their young stars for a while longer. The MLB Daily Dish is a daily feature we’re running here at MLBDD that rounds up roster…

Published

on

Rick Scuteri-USA TODAY Sports

The Mariners are bringing up two of their best prospects while the Braves will be without one of their young stars for a while longer.

The MLB Daily Dish is a daily feature we’re running here at MLBDD that rounds up roster-impacting news, rumors, and analysis. Have feedback or have something that should be shared? Hit us up at @mlbdailydish on Twitter or @MLBDailyDish on Instagram.

  • The Mariners’ former president Kevin Mather caused all sorts of havoc this past offseason when, among other things, he said that because their top prospect Jarred Kelenic declined to sign a long-term extension with the Mariners, that he was not going to start the 2021 season with the team in order to manipulate his service time. Well, that whole episode did not end well for Mather, but it didn’t stop the team from doing just that as both Jarred Kelenic AND Logan Gilbert got called up to the majors. We are sure it was because they “weren’t ready yet” and needed a handful of minor league games to become major leaguers.
  • The Braves’ Mike Soroka has had a rough road back to health over the last year or so. After rupturing his Achilles’ tendon early in the 2020 season, his rehab was delay this spring by soreness in his shoulder and his return was pushed back to June of this year. Now, the Braves got even worse news as Soroka has been feeling discomfort in his repaired Achilles and is going to have to undergo exploratory surgery.
  • While things on the health and safety front have gone largely well for the sport of baseball in 2021, we have been getting semi-regular reminders that COVID-19 is still a thing and it can most assuredly impact the games being played. Case in point: on Tuesday, it was announced that the Padres’ Fernando Tatis Jr. and Wil Myers both tested positive for the virus. For a team very much in the playoff picture, another stint without their best player is most definitely less than ideal. Fortunately, Tatis Jr. appears to be asymptomatic for the moment which does portend well for him bouncing right back.
  • It wouldn’t be a baseball season without a Mets pitching injury and for the Mets, this was the worst guy to get hurt. Despite a clean MRI earlier in the week, the team had to put the best pitcher in baseball, Jacob deGrom, on the IL due to an issue with his right side. No word yet how long he may be out.
  • The Braves are signing reliever Shane Greene to a one-year deal, reports Jon Heyman of MLB Network. While the contract is in the $1.5M range, it will likely end up at $1.1M after being prorated based on how much of the season is behind us. The 32-year old has been with the Braves since the 2019 trade deadline, throwing 52 1/3 innings of 3.27 ERA/3.87 FIP in his time with the Braves. He hit free agency at the end of last year and it certainly a welcome familiar face for a Braves bullpen that’s been less than reliable so far this season.
  • The Twins have had a bit of a rough patch of late and the news got worse on Thursday. Not only is Alex Kirilloff dealing with a wrist injury that landed him on the injured list, but their best player this season left the game early on Thursday. While it isn’t exactly a surprise that Byron Buxton is dealing with another ailment, it is still a bummer given how well he has played that he hobbled off the field with a hip strain.
  • The big news of the day was undoubtedly when the Angels announced that Albert Pujols, a future first ballot Hall of Famer who is owed a LOT of money this season, was released by the Angels. LA was set to decrease Pujols’ playing time and Pujols was not enthusiastic about that idea to say the least, so the move allows him to look for work elsewhere.
  • Tuesday was a monumental night for baseball, as affiliated minor league teams returned to action for the first time since September 2019. While the return of the minors doesn’t mean that the COVID-19 pandemic is behind us, it’s a sign that things are getting closer to normal, and it represents an avenue for hundreds of players, coaches, and broadcasters to achieve their dreams. Rays prospect Wander Franco, the top prospect in baseball according to both Baseball America and MLB Pipeline, had a stellar Triple-A debut, going 3 for 5 with a triple and two RBI.
  • Concerning news for the Brewers: Christian Yelich returned to the injured list Tuesday, just one day after being activated due to lingering back pain. Manager Craig Counsell says the Brewers and Yelich are searching for answers as the 2018 NL MVP continues to suffer through pain despite receiving a clean MRI.
  • Its never great news when a player ends up on the ground after attempting to run to first, but the news was particularly bad for Luis Robert and the Chicago White Sox. The young star was diagnosed with a torn hip flexor and won’t even be able to begin baseball activities for 12-16 weeks, which very much puts his season in jeopardy. That White Sox outfield is looking awfully thin these days.
  • The Dodgers have their own injury problems. Dustin May left his most recent start in the second inning and on Monday, it was announced that he is going to have to undergo Tommy John surgery which will put him out until at least some time next season. It’s silly how much depth that Dodgers roster has, but they can’t really afford to lose too much more talent on the pitching side.
  • The Braves have placed Travis d’Arnaud on the 60-day injured list after undergoing a pretty rough sprain to his thumb that could be more serious than initially posed. William Contreras, the young 2015 international signee, will take d’Arnaud’s spot behind the plate.
  • In some disturbing news, MLB has placed Roberto Alomar on the ineligible list, while the Blue Jays severed all of their ties with Hall of Famer. His name will be removed from the team’s “Level of Excellence” and his banner at Rogers Centre will be taken down following an investigation of sexual misconduct against him. He is now the only Hall of Famer on the ineligible list.
  • The Brewers have hit a rough speed bump early in their season, placing Corbin Burnes on the injured list. While it wasn’t immediately revealed what sent the early NY Cy Young front runner to the IL, that eludes to the fact that this stint is COVID-19 related. If that is the case, we hope it’s nothing serious with long-term effects. The 26-year-old is currently rocking a 1.53 ERA with 49 strikeouts over 29.1 innings, so missing Burnes in the rotation for an extended period of time could really do a number on the Brewers.
  • The Rays got some reinforcements for their pitching staff last week as Shane McClanahan, who was added to the team’s postseason roster during their World Series run in 2020 and had yet to make his regular season debut, was called up to the big leagues.
  • We had our first major leaguer-for-major leaguer trade of the 2021 season last week, as the Giants acquired outfielder Mike Tauchman from the Yankees in exchange for lefty reliever Wandy Peralta and a player to be named later. Tauchman has been buried on the Yankees’ depth chart this season but had a .353 OBP during his three-year tenure in New York and is an interesting addition to the Giants’ mix-and-match outfield group. Peralta, meanwhile, had a career season with San Francisco last year, and while he’s been inconsistent to start 2021, he provides some left-handed depth to the Yankees’ bullpen as they await the return of Zack Britton.
  • The Rockies have been poorly run for a while now, with general manager Jeff Bridich at the forefront of that mismanagement. They somehow made their relationship with their best player, Nolan Arenado, so bad that they had to trade him away and throw in a bunch of cash in order to do so. Well, Bridich’s time finally came as he and the team decided to mutually part ways last week.
  • The Astros have signed Martin Maldonado to a one-year extension, reports Mark Feinsand of MLB.com. The catcher is guaranteed $5M for the one-year deal with a $5M vesting option for 2023. It’s a low-risk, high-reward move for the Astros that at least buys them another year to find a replacement for Maldonado if need be.
  • Neil Walker never made an All-Star team or won a World Series, but he had a very admirable 12-year major league career, playing seven seasons for his hometown Pittsburgh Pirates, winning a Silver Slugger Award in 2014, and making over $50 million along the way. Walker announced his retirement after going unsigned all offseason. He finished his career playing in 18 games for the Phillies last summer.
  • The Nationals have placed Stephen Strasburg on the 10-day injured list. A recent MRI has shown inflammation in his right shoulder after a start last Tuesday that raised some eyebrows. He’s currently 0-1 with a 6.30 ERA over his first two starts this season.
  • Since being a highly heralded pitching prospect who was drafted #3 overall, Carlos Rodon has had to overcome several severe injuries and the label as a “bust” in his career whether it was fair or not. For at least one night, though, Rodon showed everyone what he was capable of as he threw a no-hitter (and nearly a perfect game if not for a 9th inning HBP) against the Indians.
  • James Paxton had the opposite of an ideal start to the season, as Tommy John surgery was recommended for the Mariners starter. He threw just 1.1 innings before leaving his season debut with an arm injury. Paxton is set to return to the mound in mid-2022, also missing that season opener.
  • A’s reliever Trevor Rosenthal underwent thoracic outlet surgery, Martin Gallegos of MLB.com reports. The 30-year-old kicked off this season on the IL because of a shoulder problem. While the procedure is usually a 12-week recovery period, he will be re-evaluated in eight weeks. The closer spent this offseason hunting for a long-term deal that would hopefully keep him planted for a while. What he ended up with was a 1-year, $11M deal with the Athletics. After a monster comeback in 2020, pitching a 1.90 ERA over 23.2 innings pitched between the Royals and the Padres, this feels like a devastating blow for any sort of late-career renaissance. Fingers crossed for Oakland fans that he ends up back in the bullpen sooner than anticipated.
  • The Yankees made a somewhat surprising addition, acquiring veteran infielder Rougned Odor from the Rangers in exchange for minor league outfielders Antonio Cabello and Josh Stowers. The Rangers are responsible for paying all but the league minimum to Odor, who they previously designated for assignment, and the Yankees will take a chance on a hitter who is capable of dominating right-handed pitching but has struggled to make contact in recent seasons.
  • Orlando Arcia was widely considered one of the top prospects in baseball about five years ago, but he’s mostly been a disappointment since arriving in the big leagues. The Braves will see if they can turn his career around after acquiring the 26-year-old shortstop from the Brewers in exchange for relievers Patrick Weigel and Chad Sobotka. Arcia will initially report to Atlanta’s alternate training site.
  • MLB has pulled the 2021 All-Star Game from Georgia due to new voting restrictions, and they’ll now host the Midsummer Classic at Denver’s Coors Field (we’re already excited for that Home Run Derby).
  • The Angels have signed David Fletcher to a five-year, $26M extension, reports Fabian Ardaya of The Athletic. The second baseman slashed a career best .319/.376/.425 over 230 plate appearances last season. While he offers almost no power at the plate, he’s consistent and has a jarringly low strikeout rate. The extension will begin this season and extend through 2025. The 26-year-old wouldn’t have been arbitration eligible until after this season and wouldn’t not have hit free agency until after the 2024 season. There is also a club option and buyout of $8.5M and $1.5M, respectively.
  • The health and safety protocols that the league has put in place for the 2021 season have been a hot topic given that we are amidst a vaccine rollout that should, in theory, make existing out in the world much safer and easier. Monday, MLB sent out a memo to teams saying that if at least 85% of a team’s roster becomes vaccinated, that the health protocols they are operating under will be relaxed.
  • The White Sox, fresh off an impressive run to the postseason last year, are primed to win the AL Central this year, but things just got a bit harder. It was announced last week that slugger Eloy Jimenez ruptured his pectoral tendon and will miss around 5-6 months of action as he recovers. While the White Sox do have a good number of quality bats in their lineup, Eloy’s injury is really going to put their depth to the test and place a lot of pressure on some young guys to perform.
  • One of the more exciting guys set to hit free agency after this season is shortstop Carlos Correa who, despite having trouble staying healthy in his career, would be one of the biggest names on the free agent market if he made it there. It was reported that the while Astros did offer an extension to him, Correa considered the offer so low that he now seems resigned to test the waters in free agency after the season.
  • While it doesn’t look super promising that the Astros are going to be able to lock up Carlos Correa and already lost George Springer to free agency, they did get some good news last week as they were able to lock up Lance McCullers with a five-year extension. It isn’t the marquee extension/signing they probably need to prolong their competitive window, but hey....progress.
  • After signing a one-year deal with Toronto over the offseason, former All-Star reliever Kirby Yates may never get a chance to pitch in a Blue Jays uniform. Yates underwent Tommy John surgery, knocking him out for the entire 2021 season.
  • The Royals and Salvador Perez have agreed to a monster contract extension. The deal will keep Perez in Kansas City for four more years to the tune of $82M. Slashing a career .269/.300/.449, the 30-year old was a cornerstone of the team’s 2015 World Series run. The extension also comes less than two years after Perez had Tommy John surgery and missed the entire 2019 season. Despite that, the Royals seem to have no intention of letting the franchise icon leave any time soon.
  • A few seasons ago, MLB tested out some new rules in the minor leagues that ended up being used in the major leagues, including the extra inning rule where a runner started each extra inning on second base. Now, it looks like MLB is eyeing some other changes with new rules getting tested out in the minors during the 2021 season. Such changes include an automated strike zone, limits on the shift, limits on pickoff moves, and changes to the physical bases designed to lead to less slipping and less collisions on the basepaths.

Read More

Continue Reading

Spread & Containment

Sylvester researchers, collaborators call for greater investment in bereavement care

MIAMI, FLORIDA (March 15, 2024) – The public health toll from bereavement is well-documented in the medical literature, with bereaved persons at greater…

Published

on

MIAMI, FLORIDA (March 15, 2024) – The public health toll from bereavement is well-documented in the medical literature, with bereaved persons at greater risk for many adverse outcomes, including mental health challenges, decreased quality of life, health care neglect, cancer, heart disease, suicide, and death. Now, in a paper published in The Lancet Public Health, researchers sound a clarion call for greater investment, at both the community and institutional level, in establishing support for grief-related suffering.

Credit: Photo courtesy of Memorial Sloan Kettering Comprehensive Cancer Center

MIAMI, FLORIDA (March 15, 2024) – The public health toll from bereavement is well-documented in the medical literature, with bereaved persons at greater risk for many adverse outcomes, including mental health challenges, decreased quality of life, health care neglect, cancer, heart disease, suicide, and death. Now, in a paper published in The Lancet Public Health, researchers sound a clarion call for greater investment, at both the community and institutional level, in establishing support for grief-related suffering.

The authors emphasized that increased mortality worldwide caused by the COVID-19 pandemic, suicide, drug overdose, homicide, armed conflict, and terrorism have accelerated the urgency for national- and global-level frameworks to strengthen the provision of sustainable and accessible bereavement care. Unfortunately, current national and global investment in bereavement support services is woefully inadequate to address this growing public health crisis, said researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations.  

They proposed a model for transitional care that involves firmly establishing bereavement support services within healthcare organizations to ensure continuity of family-centered care while bolstering community-based support through development of “compassionate communities” and a grief-informed workforce. The model highlights the responsibility of the health system to build bridges to the community that can help grievers feel held as they transition.   

The Center for the Advancement of Bereavement Care at Sylvester is advocating for precisely this model of transitional care. Wendy G. Lichtenthal, PhD, FT, FAPOS, who is Founding Director of the new Center and associate professor of public health sciences at the Miller School, noted, “We need a paradigm shift in how healthcare professionals, institutions, and systems view bereavement care. Sylvester is leading the way by investing in the establishment of this Center, which is the first to focus on bringing the transitional bereavement care model to life.”

What further distinguishes the Center is its roots in bereavement science, advancing care approaches that are both grounded in research and community-engaged.  

The authors focused on palliative care, which strives to provide a holistic approach to minimize suffering for seriously ill patients and their families, as one area where improvements are critically needed. They referenced groundbreaking reports of the Lancet Commissions on the value of global access to palliative care and pain relief that highlighted the “undeniable need for improved bereavement care delivery infrastructure.” One of those reports acknowledged that bereavement has been overlooked and called for reprioritizing social determinants of death, dying, and grief.

“Palliative care should culminate with bereavement care, both in theory and in practice,” explained Lichtenthal, who is the article’s corresponding author. “Yet, bereavement care often is under-resourced and beset with access inequities.”

Transitional bereavement care model

So, how do health systems and communities prioritize bereavement services to ensure that no bereaved individual goes without needed support? The transitional bereavement care model offers a roadmap.

“We must reposition bereavement care from an afterthought to a public health priority. Transitional bereavement care is necessary to bridge the gap in offerings between healthcare organizations and community-based bereavement services,” Lichtenthal said. “Our model calls for health systems to shore up the quality and availability of their offerings, but also recognizes that resources for bereavement care within a given healthcare institution are finite, emphasizing the need to help build communities’ capacity to support grievers.”

Key to the model, she added, is the bolstering of community-based support through development of “compassionate communities” and “upskilling” of professional services to assist those with more substantial bereavement-support needs.

The model contains these pillars:

  • Preventive bereavement care –healthcare teams engage in bereavement-conscious practices, and compassionate communities are mindful of the emotional and practical needs of dying patients’ families.
  • Ownership of bereavement care – institutions provide bereavement education for staff, risk screenings for families, outreach and counseling or grief support. Communities establish bereavement centers and “champions” to provide bereavement care at workplaces, schools, places of worship or care facilities.
  • Resource allocation for bereavement care – dedicated personnel offer universal outreach, and bereaved stakeholders provide input to identify community barriers and needed resources.
  • Upskilling of support providers – Bereavement education is integrated into training programs for health professionals, and institutions offer dedicated grief specialists. Communities have trained, accessible bereavement specialists who provide support and are educated in how to best support bereaved individuals, increasing their grief literacy.
  • Evidence-based care – bereavement care is evidence-based and features effective grief assessments, interventions, and training programs. Compassionate communities remain mindful of bereavement care needs.

Lichtenthal said the new Center will strive to materialize these pillars and aims to serve as a global model for other health organizations. She hopes the paper’s recommendations “will cultivate a bereavement-conscious and grief-informed workforce as well as grief-literate, compassionate communities and health systems that prioritize bereavement as a vital part of ethical healthcare.”

“This paper is calling for healthcare institutions to respond to their duty to care for the family beyond patients’ deaths. By investing in the creation of the Center for the Advancement of Bereavement Care, Sylvester is answering this call,” Lichtenthal said.

Follow @SylvesterCancer on X for the latest news on Sylvester’s research and care.

# # #

Article Title: Investing in bereavement care as a public health priority

DOI: 10.1016/S2468-2667(24)00030-6

Authors: The complete list of authors is included in the paper.

Funding: The authors received funding from the National Cancer Institute (P30 CA240139 Nimer) and P30 CA008748 Vickers).

Disclosures: The authors declared no competing interests.

# # #


Read More

Continue Reading

International

Copper Soars, Iron Ore Tumbles As Goldman Says “Copper’s Time Is Now”

Copper Soars, Iron Ore Tumbles As Goldman Says "Copper’s Time Is Now"

After languishing for the past two years in a tight range despite recurring…

Published

on

Copper Soars, Iron Ore Tumbles As Goldman Says "Copper's Time Is Now"

After languishing for the past two years in a tight range despite recurring speculation about declining global supply, copper has finally broken out, surging to the highest price in the past year, just shy of $9,000 a ton as supply cuts hit the market; At the same time the price of the world's "other" most important mined commodity has diverged, as iron ore has tumbled amid growing demand headwinds out of China's comatose housing sector where not even ghost cities are being built any more.

Copper surged almost 5% this week, ending a months-long spell of inertia, as investors focused on risks to supply at various global mines and smelters. As Bloomberg adds, traders also warmed to the idea that the worst of a global downturn is in the past, particularly for metals like copper that are increasingly used in electric vehicles and renewables.

Yet the commodity crash of recent years is hardly over, as signs of the headwinds in traditional industrial sectors are still all too obvious in the iron ore market, where futures fell below $100 a ton for the first time in seven months on Friday as investors bet that China’s years-long property crisis will run through 2024, keeping a lid on demand.

Indeed, while the mood surrounding copper has turned almost euphoric, sentiment on iron ore has soured since the conclusion of the latest National People’s Congress in Beijing, where the CCP set a 5% goal for economic growth, but offered few new measures that would boost infrastructure or other construction-intensive sectors.

As a result, the main steelmaking ingredient has shed more than 30% since early January as hopes of a meaningful revival in construction activity faded. Loss-making steel mills are buying less ore, and stockpiles are piling up at Chinese ports. The latest drop will embolden those who believe that the effects of President Xi Jinping’s property crackdown still have significant room to run, and that last year’s rally in iron ore may have been a false dawn.

Meanwhile, as Bloomberg notes, on Friday there were fresh signs that weakness in China’s industrial economy is hitting the copper market too, with stockpiles tracked by the Shanghai Futures Exchange surging to the highest level since the early days of the pandemic. The hope is that headwinds in traditional industrial areas will be offset by an ongoing surge in usage in electric vehicles and renewables.

And while industrial conditions in Europe and the US also look soft, there’s growing optimism about copper usage in India, where rising investment has helped fuel blowout growth rates of more than 8% — making it the fastest-growing major economy.

In any case, with the demand side of the equation still questionable, the main catalyst behind copper’s powerful rally is an unexpected tightening in global mine supplies, driven mainly by last year’s closure of a giant mine in Panama (discussed here), but there are also growing worries about output in Zambia, which is facing an El Niño-induced power crisis.

On Wednesday, copper prices jumped on huge volumes after smelters in China held a crisis meeting on how to cope with a sharp drop in processing fees following disruptions to supplies of mined ore. The group stopped short of coordinated production cuts, but pledged to re-arrange maintenance work, reduce runs and delay the startup of new projects. In the coming weeks investors will be watching Shanghai exchange inventories closely to gauge both the strength of demand and the extent of any capacity curtailments.

“The increase in SHFE stockpiles has been bigger than we’d anticipated, but we expect to see them coming down over the next few weeks,” Colin Hamilton, managing director for commodities research at BMO Capital Markets, said by phone. “If the pace of the inventory builds doesn’t start to slow, investors will start to question whether smelters are actually cutting and whether the impact of weak construction activity is starting to weigh more heavily on the market.”

* * *

Few have been as happy with the recent surge in copper prices as Goldman's commodity team, where copper has long been a preferred trade (even if it may have cost the former team head Jeff Currie his job due to his unbridled enthusiasm for copper in the past two years which saw many hedge fund clients suffer major losses).

As Goldman's Nicholas Snowdon writes in a note titled "Copper's time is now" (available to pro subscribers in the usual place)...

... there has been a "turn in the industrial cycle." Specifically according to the Goldman analyst, after a prolonged downturn, "incremental evidence now points to a bottoming out in the industrial cycle, with the global manufacturing PMI in expansion for the first time since September 2022." As a result, Goldman now expects copper to rise to $10,000/t by year-end and then $12,000/t by end of Q1-25.’

Here are the details:

Previous inflexions in global manufacturing cycles have been associated with subsequent sustained industrial metals upside, with copper and aluminium rising on average 25% and 9% over the next 12 months. Whilst seasonal surpluses have so far limited a tightening alignment at a micro level, we expect deficit inflexions to play out from quarter end, particularly for metals with severe supply binds. Supplemented by the influence of anticipated Fed easing ahead in a non-recessionary growth setting, another historically positive performance factor for metals, this should support further upside ahead with copper the headline act in this regard.

Goldman then turns to what it calls China's "green policy put":

Much of the recent focus on the “Two Sessions” event centred on the lack of significant broad stimulus, and in particular the limited property support. In our view it would be wrong – just as in 2022 and 2023 – to assume that this will result in weak onshore metals demand. Beijing’s emphasis on rapid growth in the metals intensive green economy, as an offset to property declines, continues to act as a policy put for green metals demand. After last year’s strong trends, evidence year-to-date is again supportive with aluminium and copper apparent demand rising 17% and 12% y/y respectively. Moreover, the potential for a ‘cash for clunkers’ initiative could provide meaningful right tail risk to that healthy demand base case. Yet there are also clear metal losers in this divergent policy setting, with ongoing pressure on property related steel demand generating recent sharp iron ore downside.

Meanwhile, Snowdon believes that the driver behind Goldman's long-running bullish view on copper - a global supply shock - continues:

Copper’s supply shock progresses. The metal with most significant upside potential is copper, in our view. The supply shock which began with aggressive concentrate destocking and then sharp mine supply downgrades last year, has now advanced to an increasing bind on metal production, as reflected in this week's China smelter supply rationing signal. With continued positive momentum in China's copper demand, a healthy refined import trend should generate a substantial ex-China refined deficit this year. With LME stocks having halved from Q4 peak, China’s imminent seasonal demand inflection should accelerate a path into extreme tightness by H2. Structural supply underinvestment, best reflected in peak mine supply we expect next year, implies that demand destruction will need to be the persistent solver on scarcity, an effect requiring substantially higher pricing than current, in our view. In this context, we maintain our view that the copper price will surge into next year (GSe 2025 $15,000/t average), expecting copper to rise to $10,000/t by year-end and then $12,000/t by end of Q1-25’

Another reason why Goldman is doubling down on its bullish copper outlook: gold.

The sharp rally in gold price since the beginning of March has ended the period of consolidation that had been present since late December. Whilst the initial catalyst for the break higher came from a (gold) supportive turn in US data and real rates, the move has been significantly amplified by short term systematic buying, which suggests less sticky upside. In this context, we expect gold to consolidate for now, with our economists near term view on rates and the dollar suggesting limited near-term catalysts for further upside momentum. Yet, a substantive retracement lower will also likely be limited by resilience in physical buying channels. Nonetheless, in the midterm we continue to hold a constructive view on gold underpinned by persistent strength in EM demand as well as eventual Fed easing, which should crucially reactivate the largely for now dormant ETF buying channel. In this context, we increase our average gold price forecast for 2024 from $2,090/toz to $2,180/toz, targeting a move to $2,300/toz by year-end.

Much more in the full Goldman note available to pro subs.

Tyler Durden Fri, 03/15/2024 - 14:25

Read More

Continue Reading

Government

Moderna turns the spotlight on long Covid with new initiatives

Moderna’s latest Covid effort addresses the often-overlooked chronic condition of long Covid — and encourages vaccination to reduce risks. A digital…

Published

on

Moderna’s latest Covid effort addresses the often-overlooked chronic condition of long Covid — and encourages vaccination to reduce risks. A digital campaign debuted Friday along with a co-sponsored event in Detroit offering free CT scans, which will also be used in ongoing long Covid research.

In a new video, a young woman describes her three-year battle with long Covid, which includes losing her job, coping with multiple debilitating symptoms and dealing with the negative effects on her family. She ends by saying, “The only way to prevent long Covid is to not get Covid” along with an on-screen message about where to find Covid-19 vaccines through the vaccines.gov website.

Kate Cronin

“Last season we saw people would get a flu shot, but they didn’t always get a Covid shot,” said Moderna’s Chief Brand Officer Kate Cronin. “People should get their flu shot, but they should also get their Covid shot. There’s no risk of long flu, but there is the risk of long-term effects of Covid.”

It’s Moderna’s “first effort to really sound the alarm,” she said, and the debut coincides with the second annual Long Covid Awareness Day.

An estimated 17.6 million Americans are living with long Covid, according to the latest CDC data. About four million of them are out of work because of the condition, resulting in an estimated $170 billion in lost wages.

While HHS anted up $45 million in grants last year to expand long Covid support initiatives along with public health campaigns, the condition is still often ignored and underfunded.

“It’s not just about the initial infection of Covid, but also if you get it multiple times, your risks goes up significantly,” Cronin said. “It’s important that people understand that.”

Read More

Continue Reading

Trending